Achilles Therapeutics (NASDAQ: ACHL) Stock Information | RedChip

Achilles Therapeutics (NASDAQ: ACHL) Listen to this Section


$0.75
-0.0099 ( -1.30% ) 77.0K

Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.

Market Data


Open


$0.75

Previous close


$0.76

Volume


77.0K

Market cap


$31.60M

Day range


$0.74 - $0.76

52 week range


$0.74 - $1.76

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
6-k Quarterly Reports 69 Aug 14, 2024
6-k Quarterly Reports 1 Aug 05, 2024
6-k Quarterly Reports 1 Jun 27, 2024
6-k Quarterly Reports 11 May 24, 2024
6-k Quarterly Reports 3 May 17, 2024
6-k Quarterly Reports 5 May 08, 2024
20-f Annual reports 98 Apr 04, 2024
6-k Quarterly Reports 5 Nov 13, 2023
6-k Quarterly Reports 3 Sep 22, 2023
6-k Quarterly Reports 69 Aug 04, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.